IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%

MT Newswires

06/16

IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.

Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.

The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.

The move also comes after the company secured a $41 million US Department of Defense contract.

The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2643735919"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2643735919\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2643735919?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 12:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643735919","market":"sg","top_or_hot":-1,"title":"IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%","media":"MT Newswires","content":"<html><body><p> IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.</p><p>The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.</p><p>The move also comes after the company secured a $41 million US Department of Defense contract.</p><p>The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time smaller\">2026-06-16 12:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.</p><p>The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.</p><p>The move also comes after the company secured a $41 million US Department of Defense contract.</p><p>The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6506","symbol_name":"製藥與醫學研究概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2643735919","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2643735919","pubTimestamp":1781584977,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"IX Biopharma  will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.The move also comes after the company secured a $41 million US Department of Defense contract.The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6506":"制药与医学研究概念","BK6079":"制药","42C.SI":"IX生物制药"},"translate_title":"IX Biopharma将生产设备迁至美国；股价下跌8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"42C.SI":0.9},"content_text":"IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.The move also comes after the company secured a $41 million US Department of Defense contract.The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}